BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31281491)

  • 21. Optimizing scan time and bayesian penalized likelihood reconstruction algorithm in copper-64 PET/CT imaging: a phantom study.
    Monsef A; Sheikhzadeh P; Steiner JR; Sadeghi F; Yazdani M; Ghafarian P
    Biomed Phys Eng Express; 2024 May; 10(4):. PubMed ID: 38608316
    [No Abstract]   [Full Text] [Related]  

  • 22. Impact of penalizing factor in a block-sequential regularized expectation maximization reconstruction algorithm for
    Bjöersdorff M; Oddstig J; Karindotter-Borgendahl N; Almquist H; Zackrisson S; Minarik D; Trägårdh E
    EJNMMI Phys; 2019 Mar; 6(1):5. PubMed ID: 30900064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of [
    Cox CPW; Brabander T; Vegt E; de Lussanet de la Sablonière QG; Graven LH; Verburg FA; Segbers M
    EJNMMI Phys; 2024 Mar; 11(1):27. PubMed ID: 38488989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BSREM Reconstruction for Improved Detection of In-Transit Metastases With Digital FDG-PET/CT in Patients With Malignant Melanoma.
    Aljared A; Alharbi AA; Huellner MW
    Clin Nucl Med; 2018 May; 43(5):370-371. PubMed ID: 29485444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions.
    Afshar-Oromieh A; Hetzheim H; Kratochwil C; Benesova M; Eder M; Neels OC; Eisenhut M; Kübler W; Holland-Letz T; Giesel FL; Mier W; Kopka K; Haberkorn U
    J Nucl Med; 2015 Nov; 56(11):1697-705. PubMed ID: 26294298
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Caroli P; Sandler I; Matteucci F; De Giorgi U; Uccelli L; Celli M; Foca F; Barone D; Romeo A; Sarnelli A; Paganelli G
    Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2035-2044. PubMed ID: 29922948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biphasic ⁶⁸Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma.
    Sahlmann CO; Meller B; Bouter C; Ritter CO; Ströbel P; Lotz J; Trojan L; Meller J; Hijazi S
    Eur J Nucl Med Mol Imaging; 2016 May; 43(5):898-905. PubMed ID: 26563122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early dynamic imaging in
    Uprimny C; Kroiss AS; Decristoforo C; Fritz J; Warwitz B; Scarpa L; Roig LG; Kendler D; von Guggenberg E; Bektic J; Horninger W; Virgolini IJ
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):765-775. PubMed ID: 27900519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association of tumor-to-background ratios and SUVmax deviations related to point spread function and time-of-flight F18-FDG-PET/CT reconstruction in colorectal liver metastases.
    Rogasch JM; Steffen IG; Hofheinz F; Großer OS; Furth C; Mohnike K; Hass P; Walke M; Apostolova I; Amthauer H
    EJNMMI Res; 2015; 5():31. PubMed ID: 25992306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biodistribution of [(68)Ga]PSMA-HBED-CC in Patients with Prostate Cancer: Characterization of Uptake in Normal Organs and Tumour Lesions.
    Prasad V; Steffen IG; Diederichs G; Makowski MR; Wust P; Brenner W
    Mol Imaging Biol; 2016 Jun; 18(3):428-36. PubMed ID: 27038316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimization of PET reconstruction algorithm, SUV thresholding algorithm and PET acquisition time in clinical 11C-acetate PET/CT.
    Strandberg S; Hashemi A; Axelsson J; Riklund K
    PLoS One; 2018; 13(12):e0209169. PubMed ID: 30543705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimization of PET/CT image quality using the GE 'Sharp IR' point-spread function reconstruction algorithm.
    Vennart NJ; Bird N; Buscombe J; Cheow HK; Nowosinska E; Heard S
    Nucl Med Commun; 2017 Jun; 38(6):471-479. PubMed ID: 28394818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective comparison of whole-body MRI and
    Sawicki LM; Kirchner J; Buddensieck C; Antke C; Ullrich T; Schimmöller L; Boos J; Schleich C; Schaarschmidt BM; Buchbender C; Heusch P; Rabenalt R; Albers P; Antoch G; Müller HW; Hautzel H
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1542-1550. PubMed ID: 30879122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence.
    Uprimny C; Kroiss AS; Fritz J; Decristoforo C; Kendler D; von Guggenberg E; Nilica B; Maffey-Steffan J; di Santo G; Bektic J; Horninger W; Virgolini IJ
    Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1647-1655. PubMed ID: 28589253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of standard and delayed imaging to improve the detection rate of [
    Schmuck S; Nordlohne S; von Klot CA; Henkenberens C; Sohns JM; Christiansen H; Wester HJ; Ross TL; Bengel FM; Derlin T
    Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):960-968. PubMed ID: 28280856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Applications of both time of flight and point spread function in brain PET image reconstruction.
    Shao X; Shao X; Wang X; Wang Y
    Nucl Med Commun; 2016 Apr; 37(4):422-7. PubMed ID: 26637071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation and Optimization of a New PET Reconstruction Algorithm, Bayesian Penalized Likelihood Reconstruction, for Lung Cancer Assessment According to Lesion Size.
    Otani T; Hosono M; Kanagaki M; Onishi Y; Matsubara N; Kawabata K; Kimura H
    AJR Am J Roentgenol; 2019 Aug; 213(2):W50-W56. PubMed ID: 30995096
    [No Abstract]   [Full Text] [Related]  

  • 38. Image enhancement of whole-body oncology [
    Mehranian A; Wollenweber SD; Walker MD; Bradley KM; Fielding PA; Su KH; Johnsen R; Kotasidis F; Jansen FP; McGowan DR
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):539-549. PubMed ID: 34318350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Translation and First In-Human Use of [
    Eppard E; de la Fuente A; Benešová M; Khawar A; Bundschuh RA; Gärtner FC; Kreppel B; Kopka K; Essler M; Rösch F
    Theranostics; 2017; 7(18):4359-4369. PubMed ID: 29158832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative evaluation of PSMA PET imaging using a realistic anthropomorphic phantom and shell-less radioactive epoxy lesions.
    Fedrigo R; Kadrmas DJ; Edem PE; Fougner L; Klyuzhin IS; Petric MP; Bénard F; Rahmim A; Uribe C
    EJNMMI Phys; 2022 Jan; 9(1):2. PubMed ID: 35032234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.